More than a decade ago, GLP-1 drugs began being marketed for weight loss. Sexenda was approved in the U.S. in 2014, and ...

ChatGPT is the trending tool, which is being used for almost everything. The powerful productivity tool can write emails and ...

Ionis is up ~25%. Explore why Olezarsen, recent approvals, and upcoming catalysts could drive more upside. Click here to read ...

We must build a world where trans people don’t have to be resilient just to stay alive.